In detail, PPARγ agonists, HDAC inhibitors, PI3K/AKT inhibitors and MEK/ERK inhibitors, have been recommended for NIS over-expression and have caused improved iodine uptake in thyroid cancers [121]. The gene discussed is SLC5A5; the disease is thyroid cancer.